Prado-Montes OE

Language: Spanish
References: 20
Page: 241-243
PDF size: 51.32 Kb.

ABSTRACT

The drawbacks associated with antibiotic-based treatment of infectious diseases including an increase in multidrug-resistant strains and adverse reactions have lead to the search of antimicrobial peptide elicitors (APE), harmless substances that boost an overexpression of innate immunity genes. Knowledge on innate immunity activation pathways and their interactions with adaptive immunity would lead to more effective, faster and safer APE-based treatments to battle infections which still are a common public health problem worldwide.

REFERENCES

1. Raqib R, Sarker P, Bergman P, Ara G, Lindh M, Sack DA, et al. Improved outcome in shigellosis associated with butyrate induction of an endogenous peptide antibiotic. Proc Natl Acad Sci USA 2006;103:9178-9183.

2. Baldo BA, Zhao Z, Pham NH. Antibiotic allergy: immunochemical and clinical considerations. Curr Allergy Asthma Rep 2008;8:49-55.

3. Cunha BA. Antibiotic side effects. Med Clin North Am 2001;85:149-185.

4. Schroder JM, Harder J. Antimicrobial skin peptides and proteins. Cell Mol Life Sci 2006;63:469-486.

5. Islam D, Bandholtz L, Nilsson J, Wigzell H, Christensson B, Agerberth B, et al. Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator. Nat Med 2001;7:180-185.

6. Zasloff M. Inducing endogenous antimicrobial peptides to battle infections. Proc Natl Acad Sci USA 2006;103:8913-8914.

7. Sherman H, Chapnik N, Froy O. Albumin and amino acids upregulate theexpression of human beta-defensin 1. Mol Immunol 2006;43:1617-1623.

8. Boirivant M, Strober W. The mechanism of action of probiotics. Curr Opin Gastroenterol 2007;23:679-692.

9. Wehkamp J, Fellermann K, Stange EF. Human defensins in Crohn’s disease. Chem Immunol Allergy 2005;86:42-54.

10. Wehkamp J, Wang G, Kubler I, Nuding S, Gregorieff A, Schnabel A, et al. The Paneth cell alpha-defensin deficiency of ileal Crohn’s disease is linked to Wnt/Tcf-4. J Immunol 2007;179:3109-3118.

11. Voss E, Wehkamp J, Wehkamp K, Stange EF, Schroder JM, Harder J. NOD2/CARD15 mediates induction of the antimicrobial peptide human betadefensin-2. J Biol Chem 2006;281:2005-2011.

12. Fellermann K, Stange DE, Schaeffeler E, Schmalzl H, Wehkamp J, Bevins CL, et al. A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon. Am J Hum Genet 2006;79:439-448.

13. Kocsis AK, Lakatos PL, Somogyvari F, Fuszek P, Papp J, Fischer S, et al. Association of beta-defensin 1 single nucleotide polymorphisms with Crohn’s disease. Scand J Gastroenterol 2008;43:299-307.

14. Lakatos PL, Altorjay I, Mandi Y, Lakatos L, Tumpek J, Kovacs A, et al. Interaction between seroreactivity to microbial antigens and genetics in Crohn’s disease: is there a role for defensins? Tissue Antigens 2008;71:552-559.

15. Schlee M, Wehkamp J, Altenhoefer A, Oelschlaeger TA, Stange EF, Fellermann K. Induction of human beta-defensin 2 by the probiotic Escherichia coli Nissle 1917 is mediated through flagellin. Infect Immun 2007;75:2399-2407.

16. Wehkamp J, Schmid M, Fellermann K, Stange EF. Defensin deficiency, intestinal microbes, and the clinical phenotypes of Crohn’s disease. J Leukoc Biol 2005;77:460-465.

17. Schlee M, Harder J, Koten B, Stange EF, Wehkamp J, Fellermann K. Probiotic lactobacilli and VSL#3 induce enterocyte beta-defensin 2. Clin Exp Immunol 2008;151:528-535.

18. Wehkamp J, Stange EF. A new look at Crohn’s disease: breakdown of the mucosal antibacterial defense. Ann N Y Acad Sci 2006;1072:321-331.

19. Selsted ME, Ouellette AJ. Mammalian defensins in the antimicrobial immune response. Nat Immunol 2005;6:551-557.

20. Shi J, Aono S, Lu W, Ouellette AJ, Hu X, Ji Y, et al. A novel role for defensins in intestinal homeostasis: regulation of IL-1beta secretion. J Immunol 2007;179:1245-1253.